Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle

Since its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news